Ketamine Therapy Experiential Education Study — KTEES1

Psychedelic Experiences Clinical Trial

Official title:
Effects of a Personal Ketamine-assisted Therapy Experience on Clinicians' Therapeutic Competencies Within a Psychedelic-assisted Therapy Training Program

Status Not yet recruiting

Clinical Trial Summary

This study investigates the use of low-dose (0.5-0.75 mg/kg; maximum dose of 60 mg regardless of body weight) ketamine hydrochloride injection, USP administered intramuscularly to healthy clinicians as part of an experiential learning practice within a psychedelic-assisted therapy (PAT) training program. The primary objective of this study is to test the hypothesis that competencies required for mental healthcare professionals providing PAT are enhanced by undergoing a single ketamine-assisted therapy experience, as part of a PAT training program. Primary outcomes of this study are self-reported measures of therapeutic efficacy and competency for providing both general and psychedelic-assisted therapy, measured at baseline and four weeks following an academic in-person retreat with optional ketamine administration. Secondary endpoints include measures of personality and magnitude of perceived mystical experiences. Individual changes in scores across time will be calculated, and differences in therapeutic efficacy and competency between clinician trainees who choose to participate in a personal ketamine-assisted therapy session and those who do not will be assessed.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05468047
Study type	Interventional
Source	Integrative Psychiatry Institute
Contact
Status	Not yet recruiting
Phase	Early Phase 1
Start date	September 2022
Completion date	September 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05042765` - Entheogen Resurgence
Enrolling by invitation	`NCT05592379` - Consciousness, Psilocybin, and Well-Being	Phase 1
Completed	`NCT04842045` - Pilot RECAP Study in Healthy Volunteers	Phase 1
Completed	`NCT04965740` - Exploring Medically Perceived Benefits, Use and Interest in Psychedelics and Cannabinoids
Not yet recruiting	`NCT06450210` - Safety for Home Administration of Microdose Psilocybin Use	Phase 1
Recruiting	`NCT05698511` - Neural and Physiological Correlates of Psychedelic Sub-states	Phase 1
Withdrawn	`NCT05252598` - Mood and Cognitive Effects of Psilocybin in Healthy Participants	Early Phase 1
Terminated	`NCT04424225` - Visual Surround Suppression and Perceptual Expectation Under Psilocybin	Phase 1
Not yet recruiting	`NCT05866471` - Pairing Psilocybin With Transcutaneous Auricular Vagus Nerve Stimulation	Phase 1